Molecular Diagnostics Market: Global Industry Analysis and Forecast 2021-2027: by Product, Technique, End-User, Application and Region.

Molecular Diagnostics Market is anticipated to reach US$ 31.94 Bn. by 2027 from US$ 16.80 Bn. in 2020 at a CAGR of 11.3% during a forecast period. Molecular diagnostics, also known as molecular pathology, is evaluating the sequences of DNA or RNA, the unique genetic code contained in our cells, for red flags that might indicate the advent of a certain disease. The discipline has grown dramatically in recent years as a result of advancements in the pharmaceutical and healthcare industries, as well as advances in next-generation scientific sequencing. Molecular Diagnostics Market To know about the Research Methodology :- Request Free Sample Report In report, 2020 is considered a base year however 2020’s numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.

Molecular Diagnostics Market Dynamics

The older population is affected by chronic ailments such as lung disease, Parkinson's disease, heart disease, and diabetes, which has propelled the molecular diagnostics market. According to the Centres for Disease Control and Prevention (CDC), Alzheimer's disease and dementia are most common in those aged 60 and higher, and the risk increases with age. The prevalence of age-related chronic illness is rising in both developed and developing countries, driving the molecular diagnostics market to new heights throughout the forecast period. Molecular diagnostics provide an early-stage diagnosis of a variety of disorders, allowing healthcare practitioners to make better judgments at the commencement of therapeutic therapy. The results of molecular diagnostics help patients achieve better and more favourable health outcomes. Such a favourable setting is expected to propel the molecular diagnostics market forward over the forecast period. The molecular diagnostics business is trending northward, and the expanding geriatric population presents a profitable growth opportunity for the market's major players. Restraints: A molecular diagnostic device is costly. The variable costs of the reagents required, as well as those set by the suppliers, contribute to the total cost. Additional expenditures include maintenance and insurance, laboratory supervision, and overhead costs (such as utilities, space, and administration). Only major hospitals and reference laboratories with substantial capital budgets may be able to afford the high volume of molecular diagnostic tools. Most small laboratories, physician offices, and solo practitioners do not have capital budgets, thus they may not be able to buy a large or very large analyser. As a result, high-cost constraints may limit the market's growth.

Molecular Diagnostics Market Segmentation Analysis

By Product, over the forecast period, the Instruments segment is expected to have a significant market share. In the assessment of illness prognosis and therapeutic response, as well as the discovery of the minimum residual disease, molecular diagnostics plays a critical role. Due to advancements in chemistries and equipment, such as automation, integration, throughput, and the ability to use the instrumentation in a random-access mode, molecular diagnostics has grown in the last years. The influence of COVID-19 on molecular diagnostics equipment is beneficial since numerous devices for COVID-19 diagnosis were authorized by the US FDA during the pandemic. For example, FDA approved an update in July 2020 to include the Promega Maxwell RSC 48 as a permitted extraction instrument for use with the CDC 2019-nCoV rRT-PCR Diagnostic Panel. High-performance liquid chromatography (HPLC), mass spectrometry (MS), and nuclear magnetic resonance (NMR) are among the instrumental techniques used in this market, as are real-time PCR, and enzyme-linked immunosorbent assay (ELISA). By Technique, over the forecast period, the polymerase chain reaction (PCR) segment is expected to have considerable revenue growth. Increased use of PCR to identify numerous infectious organisms, increased demand for RT-PCR in COVID-19 testing, and technological advancements in PCR methods are all contributing to high revenue growth. By Application, in the global molecular diagnostics market in 2020, the infectious diseases segment accounted for the greatest revenue share. The increased frequency of infectious illnesses throughout the world, as well as the necessity for early identification and treatment, is driving demand for improved molecular diagnostic tests. Molecular Diagnostics Market

Molecular Diagnostics Market Regional Insight

North America is expected to have a strong market growth rate, with a CAGR of xx percent by 2027. North America is expected to dominate the global Molecular Diagnostics market, while Asia Pacific is expected to grow at a CAGR of xx percent. The growing elderly population and the installation of new health facilities are driving market growth in this region. Furthermore, North America dominates the market due to the availability of breakthrough molecular diagnostics technologies, well-established diagnostic systems, patient awareness, and technical improvements. The FDA and governments are investing in the development of healthy products in the Asia Pacific, which is driving the market growth. Rising FDA and government investment in the construction of healthcare infrastructure has fuelled market expansion in the Asia Pacific, particularly in countries like India, China, and Vietnam. The US Centres for Disease Control and Prevention (CDC) employed a one-step PCR method to diagnose COVID-19 during the pandemic. The experiment was performed by extracting RNA from the sample and mixing it with the master mix, which included forward and reverse primers, nuclease-free water, and the reaction mixture (reverse transcriptase, polymerase, nucleotides, magnesium, and other additives). In the United States, for example, antigen tests and nucleic acid amplification tests (NAATs) were utilized as diagnostic tests to diagnose SARS-CoV-2 infection, according to the Centres for Disease Control and Prevention (CDC). Report Objectives: • Landscape analysis of the Molecular Diagnostics Market • competitive benchmarking • Past and current status of the industry with the forecasted market size and trends • Evaluation of potential key players that include market leaders, followers, and new entrants • Technology trends • Potential impact of micro-economic factors of the market • External and Internal factors affecting market have been analyzed The report also helps in understanding the Molecular Diagnostics Market dynamics, structure by analyzing the market segments and project the Molecular Diagnostics Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Molecular Diagnostics Market make the report investor’s guide.

Molecular Diagnostics Market Scope: Inquire before buying

Molecular Diagnostics Market
Report Coverage Details
Base Year: 2020 Forecast Period: 2021-2027
Historical Data: 2016 to 2020 Market Size in 2020: US $ 16.80 Bn
Forecast Period 2021 to 2027 CAGR: 11.3 % Market Size in 2027: US $ 31.94 Bn.
Segments Covered: by Product • Reagents & Kits • Instruments • Services & Software
by Technique •Polymerase Chain Reaction (PCR) • Isothermal Amplification • Hybridization • Sequencing • Microarray • Others
by End-User • Hospitals & Clinics • Diagnostic Laboratories • Others
by Application • Infectious Diseases • Oncology • Genetic Tests • Others

Molecular Diagnostics Market by Region

• North America • Asia pacific • Europe • Middle East and Africa • South America

Molecular Diagnostics Market: Key Players

Hoffmann-La Roche Ltd • Hologic, Inc. • QIAGEN • Becton • Dickinson and Company • Abbott Laboratories • Cepheid • Siemens • Thermo Fisher Scientific • Agilent Technologies • Grifols, S.A. • Abbott Laboratories • Siemens Healthineers • Beckman Coulter, Inc. Frequently Asked Questions 1. What is the projected market size & growth rate of Molecular Diagnostics Market? Ans- Molecular Diagnostics Market was valued at USD 31.94 billion in 2020 and is projected to reach USD 16.80 billion by 2027, growing at a CAGR of 11.3% during the forecast period. 2. What are the key driving factor for the growth of Molecular Diagnostics Market? Ans- The older population is affected by chronic ailments such as lung disease, Parkinson's disease, heart disease, and diabetes, which has propelled the molecular diagnostics market. 3. Which Region accounted for the largest Molecular Diagnostics Market share? Ans- North America is expected to have a strong market growth rate, with a CAGR of xx percent by 2027. 4. What makes Asia Pacific a Lucrative Market for Molecular Diagnostics Market? Ans- the FDA and governments are investing in the development of healthy products in the Asia Pacific, which is driving the market growth. 5. What are the top players operating in Molecular Diagnostics Market? Ans- Hoffmann-La Roche Ltd, Hologic, Inc., QIAGEN, Becton, Dickinson and Company, Abbott Laboratories, and Cepheid.
1. Global Molecular Diagnostics Market: Research Methodology 2. Global Molecular Diagnostics Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Molecular Diagnostics Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Molecular Diagnostics Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Molecular Diagnostics Market Segmentation 4.1 Global Molecular Diagnostics Market, By Product (2020-2027) • Reagents & Kits • Instruments • Services & Software 4.2 Global Molecular Diagnostics Market, by Technique (2020-2027) • Polymerase Chain Reaction (PCR) • Isothermal Amplification • Hybridization • Sequencing • Microarray • Others 4.3. European Molecular Diagnostics Market, by End-User (2020-2027) • Hospitals & Clinics • Diagnostic Laboratories • Others 4.4. European Molecular Diagnostics Market, by Application (2020-2027) • Infectious Diseases • Oncology • Genetic Tests • Others 5. North America Molecular Diagnostics Market (2020-2027) 5.1 North American Molecular Diagnostics Market, By Product (2020-2027) • Reagents & Kits • Instruments • Services & Software 5.2 North America Molecular Diagnostics Market, by Technique (2020-2027) • Polymerase Chain Reaction (PCR) • Isothermal Amplification • Hybridization • Sequencing • Microarray • Others • 5.3. European Molecular Diagnostics Market, by End-User (2020-2027) • Hospitals & Clinics • Diagnostic Laboratories • Others 5.4. European Molecular Diagnostics Market, by Application (2020-2027) • Infectious Diseases • Oncology • Genetic Tests • Others 5.5. North America Molecular Diagnostics Market, by Country (2020-2027) • United States • Canada • Mexico 6. Asia Pacific Molecular Diagnostics Market (2020-2027) 6.1. Asia Pacific Molecular Diagnostics Market, By Product (2020-2027) 6.2. Asia Pacific Molecular Diagnostics Market, by Technique (2020-2027) 6.3. European Molecular Diagnostics Market, by End-User (2020-2027) 6.4. European Molecular Diagnostics Market, by Application (2020-2027) 6.5. Asia Pacific Molecular Diagnostics Market, by Country (2020-2027) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Molecular Diagnostics Market (2020-2027) 7.1. Middle East and Africa Molecular Diagnostics Market, By Product (2020-2027) 7.2. Middle East and Africa Molecular Diagnostics Market, by Technique (2020-2027) 7.3. European Molecular Diagnostics Market, by End-User (2020-2027) 7.4. European Molecular Diagnostics Market, by Application (2020-2027) 7.5. Middle East and Africa Molecular Diagnostics Market, by Country (2020-2027) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Molecular Diagnostics Market (2020-2027) 8.1. Latin America Molecular Diagnostics Market, By Product (2020-2027) 8.2. Latin America Molecular Diagnostics Market, by Technique (2020-2027) 8.3. European Molecular Diagnostics Market, by End-User (2020-2027) 8.4. European Molecular Diagnostics Market, by Application (2020-2027) 8.5 Latin America Molecular Diagnostics Market, by Country (2020-2027) • Brazil • Argentina • Rest Of Latin America 9. European Molecular Diagnostics Market (2020-2027) 9.1. European Molecular Diagnostics Market, By Product (2020-2027) 9.2. European Molecular Diagnostics Market, by Technique (2020-2027) 9.3. European Molecular Diagnostics Market, by End-User (2020-2027) 9.4. European Molecular Diagnostics Market, by Application (2020-2027) 9.5. European Molecular Diagnostics Market, by Country (2020-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10. Company Profile: Key players 10.1. QIAGEN 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Hoffmann-La Roche Ltd 10.3. Hologic, Inc. 10.4. QIAGEN 10.5. Becton 10.6. Dickinson and Company 10.7. Abbott Laboratories 10.8. Cepheid 10.9. Siemens 10.10. Thermo Fisher Scientific 10.11. Agilent Technologies 10.12. Grifols, S.A. 10.13. Abbott Laboratories 10.14. Siemens Healthineers 10.15. Beckman Coulter, Inc.

About This Report

Report ID 610
Category Healthcare
Published Date oct 2019
Updated Date Nov 2021
Contact Us